X-HER2
A pathology dataset and task involving the assessment of HER2 expression status, used to evaluate the performance of slide retrieval in molecular subtyping scenarios.
Timeline (last 90 days)
The study evaluated CLEAR-WSI on a comprehensive benchmark comprising two public datasets (CAMELYON16, BRACS) and one private clinical dataset (X-HER2), covering four retrieval tasks.
Compared with the strongest baseline, CLEAR-WSI improves Precision@5 across the board: CAMELYON16 by 3.10, BRACS-1 by 2.75, BRACS-2 by 1.95, and X-HER2 by 3.75.
The improvement on the X-HER2 task is the largest, possibly suggesting that diagnosis-driven refinement has more of an advantage in specific subtype classification scenarios.
All Facts (3)
The study evaluated CLEAR-WSI on a comprehensive benchmark comprising two public datasets (CAMELYON16, BRACS) and one private clinical dataset (X-HER2), covering four retrieval tasks.
50%UnverifiedCompared with the strongest baseline, CLEAR-WSI improves Precision@5 across the board: CAMELYON16 by 3.10, BRACS-1 by 2.75, BRACS-2 by 1.95, and X-HER2 by 3.75.
50%UnverifiedThe improvement on the X-HER2 task is the largest, possibly suggesting that diagnosis-driven refinement has more of an advantage in specific subtype classification scenarios.
50%